C20orf141 Inhibitors
Chromosome 20 open reading frame 141, or C20orf141, is a protein that, as its name suggests, is encoded by a gene located within an open reading frame on chromosome 20. The open reading frame is a segment of DNA that has the potential to be translated into a protein, and C20orf141 is the protein product of one such segment.Proteins encoded by open reading frames in the human genome can have diverse functions, including but not limited to enzymatic activity, structural roles, signaling, and regulation of gene expression. The functional ambiguity of C20orf141 means that detailed biochemical, structural, and cell biology studies are necessary to understand its role in human biology.Given its chromosomal location, C20orf141 might be involved in the complex network of genetic regulation and protein-protein interactions that dictate various cellular processes. Alterations in genes like C20orf141 can sometimes be associated with specific phenotypes or diseases, although such connections must be established through detailed genetic and molecular biology research.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A, an HDAC inhibitor, could indirectly influence C20orf141 by modifying gene expression and chromatin structure. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may affect C20orf141 indirectly by altering gene expression patterns through DNA methylation changes. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib, by inhibiting the proteasome, could indirectly impact C20orf141 by affecting protein degradation pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, might influence C20orf141 indirectly through cellular growth and proliferation pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, could affect C20orf141 indirectly by modulating signaling pathways involved in cell survival and metabolism. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $246.00 $490.00 $536.00 | 16 | |
Ruxolitinib could indirectly impact C20orf141 by modulating JAK/STAT signaling pathways, potentially relevant to its function or expression. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
XAV-939, a Wnt/β-catenin pathway inhibitor, may indirectly impact C20orf141 by modulating cell signaling pathways related to development and proliferation. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126, an inhibitor of the MAPK/ERK pathway, might indirectly affect C20orf141 by influencing cell differentiation and growth pathways. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
17-AAG, an HSP90 inhibitor, could affect C20orf141 indirectly by impacting protein folding and stability. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine, an autophagy modulator, could have indirect implications for C20orf141 through its role in cellular degradation processes. | ||||||